MicroRNA mediated signaling and metabolic reprogramming in oral squamous cell carcinoma

Gunjankumari Patel1, Sitaram Harihar2

  • 1Department of Experimental Surgery, McGill University, 1650 Cedar Avenue, T5-110, Montreal, QC, H3G 1A4, Canada.

Insights

This review explores microRNAs (miRNAs) in Oral Squamous Cell Carcinoma (OSCC), focusing on their role in metabolic reprogramming. Understanding these miRNAs can improve early detection and treatment strategies for this aggressive oral cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Oral Squamous Cell Carcinoma (OSCC) is an aggressive cancer with poor survival rates due to metastasis and recurrence.
  • Dysregulated signaling pathways drive OSCC progression, affecting tumor growth, proliferation, and resistance to cell death.
  • Aberrant signaling is crucial for metabolic adaptation in OSCC, enabling tumors to thrive in various microenvironments.

Purpose of the Study:

  • To review the role of specific microRNAs (miRNAs) in Oral Squamous Cell Carcinoma (OSCC).
  • To highlight how miRNAs modulate signaling pathways involved in metabolic reprogramming within OSCC tumors.
  • To identify miRNAs as potential diagnostic indicators and predictors of disease progression in OSCC.

Main Methods:

  • Literature review of studies on miRNAs and signaling pathways in OSCC.
  • Analysis of miRNA expression patterns and their regulatory functions.
  • Focus on the link between miRNA-mediated signaling and metabolic adaptation in oral cancer.

Main Results:

  • Multiple miRNAs regulate key signaling cascades in OSCC by controlling gene expression.
  • Specific miRNA expression in OSCC tumors correlates with diagnostic potential and disease progression.
  • miRNAs play a significant role in the metabolic conditioning of OSCC tumors.

Conclusions:

  • miRNAs are critical regulators of signaling pathways in OSCC, influencing tumor behavior and metabolic adaptation.
  • miRNA profiling holds promise for early detection and prognosis of Oral Squamous Cell Carcinoma.
  • Targeting miRNA-mediated signaling pathways may offer novel therapeutic strategies for OSCC.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.0K
What is Cell Signaling?02:03

What is Cell Signaling?

Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate to respond to the environment.
131.0K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K
What is Metabolism?00:52

What is Metabolism?

Overview
132.0K
Cell-surface Signaling01:21

Cell-surface Signaling

Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
54.6K